Determination of the optimal dose of thymoglobulin when used as a three-day induction course for T-Cell clearance in kidney transplant recipients.

被引：0
|
作者：
Wong, WC
Pascual, M
Agrawal, N
Anderson, D
Cardarelli, F
Delmonico, FL
Cosimi, AB
Tolkoff-Rubin, N
机构：
[1] CHU Vaudois, Transplant Ctr, CH-1011 Lausanne, Switzerland
[2] Massachusetts Gen Hosp, Transplantat Unit, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Renal Unit, Boston, MA 02114 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：651A / 651A
页数：1
相关论文
共 22 条
  • [1] Optimal dose of thymoglobulin for induction therapy in high risk kidney transplant recipients
    Kim, Yaerim
    Kang, Seong Sik
    Park, Woo Yeong
    Jin, Kyubok
    Park, Sung Bae
    Cho, Won Hyun
    Kim, Hyoung Tae
    Han, Seungyeup
    TRANSPLANTATION, 2016, 100 (07) : S705 - S705
  • [2] Use of Thymoglobulin in Low Dose Schemes as Induction Therapy in High Risk Kidney Transplant Recipients.
    Perez-Vega, D.
    Rojas-Campos, E.
    Salvador, M. -C.
    Evangelista-Carrillo, L.
    Molina-Ruiz, F.
    Gomez-Navarro, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 318 - 318
  • [3] Basiliximab versus T-cell Depleting Induction Therapy in Elderly Kidney Transplant Recipients.
    Vranic, G.
    Shah, H.
    Thomas, B.
    Javaid, B.
    Moore, J.
    Cooper, M.
    Gilbert, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 560 - 561
  • [4] T regulatory cells after induction therapy with Campath-1H, vs Thymoglobulin vs Daclizumab in kidney transplant recipients.
    Carreno, MR
    Cirocco, R
    Mathew, J
    Ciancio, G
    Burke, GW
    Miller, J
    Esquenazi, V
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 570 - 570
  • [5] Does the Effectiveness of Thymoglobulin Induction Measured by T-Cell Depletion Correlate with the Incidence of Rejection Post Kidney Transplant
    Liu, Patty
    Stansbury, Tara
    O'Brien, Makenzie
    Moritz, Michael
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 79 - 80
  • [6] The Effect of Transient BK Viremia after T-Cell Depleting Antibody Therapy in Kidney Transplant Recipients.
    Sageshima, J.
    Ciancio, G.
    Chen, L.
    Mattiazzi, A.
    Guerra, G.
    Kupin, W.
    Roth, D.
    Ruiz, P.
    Burke, G., III
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 432 - 433
  • [7] COVID-19 Vaccination Induces a Poor Interleukin-21 Memory T-cell Response in Kidney Transplant Recipients.
    Malahe, S. R.
    den Hartog, Y.
    de Kuiper, R.
    Reijerkerk, D.
    Geers, D.
    GeurtsvanKessel, C. H.
    Kho, M. M.
    de Vries, R. D.
    Reinders, M. E.
    Baan, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 637 - 637
  • [8] Pre-Transplant Donor-Specific T-Cell Alloreactivity Is Strongly Associated with Early Acute Cellular Rejection in Kidney Transplant Recipients Not Receiving T-Cell Depleting Induction Therapy
    Crespo, Elena
    Lucia, Marc
    Cruzado, Josep M.
    Luque, Sergio
    Melilli, Edoardo
    Manonelles, Anna
    Lloberas, Nuria
    Torras, Joan
    Grinyo, Josep M.
    Bestard, Oriol
    PLOS ONE, 2015, 10 (02):
  • [9] Dichotomous T-Cell Repopulation after Anti-Thymocyte Globulin Induction Therapy in High Immunological Risk and DCD Renal Transplant Recipients.
    Telfer, S.
    Ullah, S.
    Fear, T.
    Mok, A.
    Jevnikar, A.
    Luke, P.
    Sener, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 226 - 226
  • [10] Induction with T-cell Depletional Agents Is Safe and Efficacious in the Very Elderly Kidney Transplant Recipients: An Analysis of the OPTN Database.
    Dave, H.
    Wolfe, L.
    Fattah, H.
    Kumar, D.
    King, A.
    Levy, M.
    Cotterell, A.
    Sharma, A.
    Bhati, C.
    Gupta, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 615 - 615
123